Press releases
- Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
- Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States
- Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
- Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Key statistics
On Friday, Co-Diagnostics Inc (C97:STU) closed at 0.99, 8.20% above its 52-week low of 0.915, set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.99 |
---|---|
High | 0.99 |
Low | 0.99 |
Bid | 1.02 |
Offer | 1.07 |
Previous close | 1.04 |
Average volume | 0.00 |
---|---|
Shares outstanding | 31.91m |
Free float | 30.19m |
P/E (TTM) | -- |
Market cap | 35.74m USD |
EPS (TTM) | -1.32 USD |
Data delayed at least 15 minutes, as of Jul 26 2024.
More ▼